Sun Sep 15 15:22:54 UTC 2024: ## Federated Hermes Increases Stake in IQVIA, Analysts Remain Bullish

**New York, NY** – Federated Hermes Inc., a prominent investment firm, boosted its position in IQVIA Holdings Inc. (NYSE: IQV) by 15.1% during the second quarter, according to a recent SEC filing. The move comes as several other major investors adjusted their holdings in the medical research company, indicating continued confidence in its prospects.

Federated Hermes now owns 218,306 shares of IQVIA, representing a stake worth approximately $46.16 million. Other institutional investors like Jennison Associates LLC, Cadian Capital Management LP, Nomura Holdings Inc., and PGGM Investments also made significant changes to their IQVIA portfolios during recent quarters.

Analysts remain optimistic about IQVIA’s future. Truist Financial, Morgan Stanley, Goldman Sachs Group, UBS Group, and Barclays have all issued “buy” ratings on the stock with price targets ranging from $270.00 to $300.00. According to MarketBeat, IQVIA currently holds a “Moderate Buy” rating with an average price target of $266.67.

Despite insider Eric Sherbet selling 1,300 shares of IQVIA in August, institutional investors still hold a significant 89.62% of the company’s stock.

IQVIA provides advanced analytics, technology solutions, and clinical research services to the life sciences industry worldwide. The company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

**IQVIA’s stock opened at $238.70 on Friday, with a market capitalization of $43.49 billion. The stock’s 52-week low is $167.42, and its 52-week high is $261.73.**

**Interested in more news and ratings for IQVIA? Sign up for MarketBeat.com’s FREE daily email newsletter to receive a concise summary of the latest developments.**

Read More